Echelon/In Vivo Collagen Hybridizing Peptide Sulfo-Cy7.5 Conjugate, Kit/Ea Kit/INVIVOKIT7.5

This kit contains 10 doses (24 nmoles) of the Target and 3 doses (8 nmoles) of the Control In Vivo Collagen Hybridizing Peptide Sulfo-Cy7.5 Conjugate.

The collagen hybridizing peptide (CHP) is a novel and unique peptide that specifically binds unfolded collagen chains, both?in vitro?and?in vivo.[1,2,3]?By sharing the Gly-X-Y repeating sequence of natural collagen, CHP has a strong capability to hybridize with denatured collagen chains by reforming the triple helical structure, in a fashion similar to DNA fragments annealing to complementary DNA strands. CHP is extremely specific: it has negligible affinity to intact collagen molecules due to lack of binding sites, and it is inert towards non-specific binding because of its neutral and hydrophilic nature.

The in vivo CHP incorporates our newest sequence which allows them to be directly injected into animals without having to pre-activate them with a heating step. [4]?Therefore, the in vivo CHPs will always be in their active form and will not self-hybridize once injected. [4]?The sCy7.5-CHP is a powerful in vivo tool?which enables straightforward detection of inflammation and tissue damage caused by a large variety of diseases, as well as tissue remodeling during development and aging.[3]?CHP can measure and localize mechanical injury to collagenous tissue at the molecular level.[5]

The sCy7.5-CHPs are labeled with sulfonated-cyanine 7.5 dye for near-infrared fluorescence (NIRF) detection. This wavelength offers better tissue penetration while minimizing tissue autofluorescence.

Specificity:?CHP binds to the?unfolded?triple-helical chains of?all collagen types?(e.g., I, II, III, IV, etc).[3,6]

Applications:?in vivo imaging, small animal imaging

Features

• New sequence designed for in vivo use- does not need any pre-activation step unlike CHPs for histology
• Near-infrared imaging probe minimizes the chance of autofluorescence in the gut or certain tissues
• Can be used for systemic or in situ injection
• Signal lasts at target sites for days, allowing for imaging at multiple time points with a single dose
• High affinity and unparalleled specificity to collagen turnover with essentially?no?nonspecific binding
• Applicable to all types of collagen from all species, relying on collagen’s secondary structure instead of any defined sequence for binding
• Stable in solution under 4 °C up to three months, eliminating the need to aliquot for storage

Key Publications

1.Targeting and mimicking collagens via triple helical peptide assemblies.?Curr.?Opin. Chem. Biol., 2013. [link]

2.Targeting collagen strands by photo-triggered triple-helix hybridization.?Proc. Natl. Acad. Sci. U.S.A., 2012. [link]

3.In situ?imaging of tissue remodeling with collagen hybridizing peptides.?ACS Nano, 2017. [link]

4.Visualizing collagen proteolysis by peptide hybridization: From 3D cell culture to?in vivo?imaging.?Biomaterials, 2018. [link]

5.Molecular level detection and localization of mechanical damage in collagen enabled by collagen hybridizing peptides.?Nat.?Commun., 2017. [link]

6.Direct detection of collagenous proteins by fluorescently labeled collagen mimetic peptides.?Bioconjug. Chem., 2013. [link]

Additional Information

• sCy7.5-CHP dose can be adjusted based on animal model or application. Current dosing is based on a mouse model.